Yeah, a tight deployment is probably safer than a loose deployment but also less useful. I think the deal making should give very minor boost to loose deployment, but this is outweighed by usefulness and safety considerations, i.e. I’m imaging the tightness of the deployment as exogenous to the dealmaking agenda.
We might deploy AIs loosely bc (i) loose deployment doesn’t significantly diminish safety, (ii) loose deployment significantly increases usefulness, (iii) the lab values usefulness more than safety. In those worlds, dealmaking has more value, because our commitments will be more credible.
Yeah, a tight deployment is probably safer than a loose deployment but also less useful. I think the deal making should give very minor boost to loose deployment, but this is outweighed by usefulness and safety considerations, i.e. I’m imaging the tightness of the deployment as exogenous to the dealmaking agenda.
We might deploy AIs loosely bc (i) loose deployment doesn’t significantly diminish safety, (ii) loose deployment significantly increases usefulness, (iii) the lab values usefulness more than safety. In those worlds, dealmaking has more value, because our commitments will be more credible.